智通财经APP讯，迅捷兴(688655.SH)发布2025年半年度报告，该公司营业收入为2.92亿元，同比增长 27.66%。归属于上市公司股东的净亏损为276.61万元。归属于上市公司股东的扣除非经常性损益的净亏 损为472.12万元。基本每股亏损为0.02元。 报告期公司收入增长利润下滑主要原因是公司新增珠海智慧样板厂投产，因投产初期人工折旧等成本费 用大幅增加使得珠海迅捷兴亏损1154.13万元;其次是公司实施2025年限制性股票激励计划，新增股份支 付费用394.71万元，同时因营收规模扩大，应收账款对应的信用减值损失同比增加161.69万元，以及财 务费用增加151.97万元。报告期内，公司产能利用率逐步提升，第二季度收入环比增长了36.65%，并呈 现稳步增长态势。伴随着产能爬升，公司盈利能力将得以快速改善。 ...

1. Report Industry Investment Rating - No information provided in the given content. 2. Report's Core View - In the first half of 2025, the company achieved an operating income of 229 million yuan, a year - on - year increase of 9.66%, and a net profit of 35.29 million yuan, a year - on - year increase of 20.40%. The company is optimistic about the development of the PEEK industry chain, and the market prospects of HAP and HDO in cosmetics raw materials are good. The company's product sales volume and gross profit margin have increased, mainly due to capacity improvement [24]. 3. Summary According to Relevant Catalogs 3.1 Research Basic Situation - Research object: New Han New Materials; Industry: Chemical raw materials; Reception time: August 26, 2025; Listed company reception personnel: Board Secretary Li Xiangfei, Securities Affairs Representative Ge Mingmin, and Financial Controller Wang Zhongyan [16]. 3.2 Detailed Research Institutions - Fund management companies: Harvest Fund (represented by Xu Heyang), Donghai Fund (represented by Zhang Yuantao), CITIC Prudential Fund (represented by Yao Sizhou), Jianxin Fund (represented by Wu Angda), Chunhou Fund (represented by Tian Wentian) [17]. - Investment companies: Shanghai Xishirun Investment (represented by Liu Chongli), Bissell (Shanghai) Investment (represented by Luo Hongyong), Shanghai Jisheng Investment (represented by Liu Qinglin) [17]. - Securities companies: Nanjing Securities (represented by Gu Shiyuan), Shenwan Hongyuan (represented by Li Shaocheng) [17]. - Others: Zhengyuan Private Fund (represented by Liu Jiasuo) [17]. 3.3 Main Content Data - **2025 Semi - annual Brief Analysis**: The company's operating income in the first half of 2025 was 229 million yuan, a year - on - year increase of 9.66%, and the net profit was 35.29 million yuan, a year - on - year increase of 20.40%. The comprehensive gross profit margin and sales net profit margin improved for two consecutive quarters, reaching 27% and 15.41% respectively. The sales volume of the company's main products increased by about 30%, among which the sales volume of DFBP, HAP, and photoinitiators increased by about 25%, and the sales volume of medical and agricultural intermediates increased by more than 50% [24]. - **Question and Answer Session**: - **DFBP sales growth reason**: Due to the continuous exploration of new application fields of PEEK, the number of new customers of PEEK has increased in the past two years. The company has maintained stable cooperation with old customers, and the orders of individual new customers have also increased [24]. - **PEEK industry prospects**: PEEK has excellent comprehensive performance, and its new attempts in fields such as aerospace, human implants, high - end manufacturing, low - altitude aircraft, and robots have added new growth momentum to the market. The company is optimistic about the development of the PEEK industry chain [24][25]. - **Market prospects of HAP and HDO in 2025**: The company's HAP product is mainly used in high - end creams and masks of well - known brands, and the use cases of some new cosmetic categories and new domestic and foreign brands are increasing. The HDO product can be directly used as a cosmetic raw material, with good moisturizing and bactericidal effects, and is used as a new type of preservative additive similar to HAP, targeting the same customer group as HAP [25]. - **Reason for the increase in the sales volume of pharmaceutical intermediates in the first half of 2025**: After the new workshop of the 8,000 - ton project was put into production, the company's production capacity was sufficient to support the development of new customers and markets for this type of product [26]. - **Factors for the recovery of the company's product gross profit margin in the first half of the year**: The main reason is the stable increase in the company's capacity utilization rate, and the fixed cost per unit product has decreased [26].

证券日报网讯凌玮科技（301373）8月25日在互动平台回答投资者提问时表示，二级市场股价的波动受 资本市场宏观经济及国际动态等多种因素综合影响，敬请广大投资者注意投资风险。公司于2023年2月8 日在深交所创业板上市后，当前及未来三年，公司业务发展的重点为推动募投项目的产能利用率、丰富 纳米二氧化硅的产品应用领域和进一步提升公司纳米二氧化硅产品的国际竞争力，不断提升主营业务的 综合竞争力和盈利能力，力求以稳健的经营成果与切实的社会责任担当回报投资者。同时，公司将根据 公司自身经营状况、未来发展规划、公司市值管理要求、行业市场等情况来决定是否实施资本公积转增 股本、股份回购，增持股份、股权激励、并购相关行业企业等资本运作方式，以实现股东利益和社会价 值最大化。 ...

Core Viewpoint - The company reported a robust growth of over 20% in its electronic adhesive business in the first half of the year, driven by rapid expansion in the consumer electronics and automotive electronics sectors, alongside steady performance in traditional businesses [1] Group 1: Business Performance - The electronic adhesive business achieved revenue of 376 million, representing a year-on-year growth of 23.5%, primarily fueled by the rapid growth in consumer electronics and automotive electronics [1] - Traditional stronghold sectors such as smart appliances and power supplies also maintained stable growth, contributing to the overall solid performance of the business [1] Group 2: Capacity Utilization - The current capacity utilization rate at the Guangzhou plant is approximately 75%, with expectations for higher utilization rates throughout 2025 as downstream orders are released and capacity continues to be absorbed [1] - The company anticipates achieving a higher capacity utilization rate for the entire year of 2025, contingent on the continued demand for electronic adhesive products [1]

Core Viewpoint - The company experienced a decline in revenue but a significant increase in net profit due to improved profit margins from lower raw material prices and higher capacity utilization [1][2][4]. Financial Performance - In H1 2025, the company's revenue was 3.591 billion, a year-on-year decrease of 9.99%, while net profit reached 390 million, an increase of 67.53% [2]. - In Q2 2025, revenue was 1.860 billion, down 13.70%, with net profit at 217 million, up 42.03% [2]. - The company declared an interim dividend of 0.15 per share, accounting for 57.67% of H1 net profit [2]. Profitability and Margins - H1 2025 gross margin improved by 5.20 percentage points to 15.20%, with net margin increasing by 5.03 percentage points to 10.86% [3]. - Q2 2025 gross margin rose by 2.01 percentage points to 15.51%, driven by lower raw material prices and increased factory utilization [3]. Operational Insights - The Vietnamese subsidiary contributed significantly to revenue, accounting for 79% of total income in H1 2025, with a net profit of 304 million, up 39.19% [2]. - The company faced a decrease in cash flow from operating activities, down 95.57% to 39.23 million, due to reduced sales and increased raw material purchases [3]. Future Outlook - Revenue projections for 2025-2027 are 8.191 billion, 8.735 billion, and 9.290 billion, with expected growth rates of 3%, 7%, and 6% respectively [4]. - Net profit forecasts for the same period are 673 million, 746 million, and 823 million, reflecting year-on-year growth of 64%, 11%, and 10% [4]. - The current market valuation corresponds to a PE ratio of 12.5X for 2025 and 11X for 2026, with a high dividend payout ratio of 95% for 2024 [4].

Summary of Wuxi Zhenhua Conference Call Company Overview - Wuxi Zhenhua has entered the selective electroplating sector through the acquisition of Wuxi Kaixiang, focusing on providing electroplating services for core engine components. The revenue from this business is projected to reach 180 million yuan in 2024, with a gross margin of 80% [2][6][14]. Core Business Insights - The company has diversified its customer base, including major clients such as SAIC Motor, Tesla, Li Auto, and Xiaomi Auto. Xiaomi Auto is experiencing rapid growth and is expected to become a significant growth driver for Wuxi Zhenhua [2][4]. - The company has established nine production bases close to its clients in regions like North China, the Yangtze River Delta, and Central China [2][5]. Financial Performance - Wuxi Zhenhua's net profit margin has significantly improved from 4.6% in 2022 to nearly 15% in 2024, aided by the integration of the selective electroplating business and cost reduction measures. The decline in steel prices has also contributed positively to the company's overall profitability [2][6][7]. - The selective electroplating business is expected to generate revenues of 150 million yuan in 2023 and increase to 180 million yuan in 2024, maintaining a gross margin of approximately 80% [6][14]. Customer and Market Dynamics - The company has a strong relationship with SAIC Motor, which has historically been a key partner. The sales of SAIC Motor's passenger vehicles have shown an 11% year-on-year increase in the first seven months of 2025, which is expected to benefit Wuxi Zhenhua's assembly business [4][11]. - Xiaomi Auto's second factory is anticipated to commence production in August 2025, which, along with the overall increase in the automotive sector, is expected to significantly boost Wuxi Zhenhua's revenue [2][8][9]. Growth Potential - The company is projected to achieve a profit of approximately 550 million yuan in 2025, reflecting a year-on-year growth of over 35%. The valuation is currently around 15-16 times earnings, indicating potential for further expansion given the accelerating performance across multiple business segments [4][15]. - The circuit business of Wuxi Zhenhua is also performing strongly, with net profit margins around 60% in 2023 and 2024. The focus on power semiconductors, including IGBT and silicon carbide, is expected to drive future growth [4][14]. Risks and Challenges - The revenue and gross margin of the assembly business for SAIC Motor are projected to decline in 2024, primarily due to high manufacturing costs and low capacity utilization. However, recovery in overall sales is expected to enhance profitability in 2025 [11]. Conclusion - Wuxi Zhenhua is positioned for significant growth driven by its strategic acquisitions, diversified customer base, and strong financial performance. The company’s focus on selective electroplating and power semiconductors presents promising opportunities for future expansion [2][15].

Core Insights - The company reported strong performance in 1H25, with revenue of 17.087 billion yuan, a year-on-year increase of 10.6%, and a net profit attributable to shareholders of 1.287 billion yuan, up 33.2% year-on-year [1][2] - The beverage business showed steady growth despite increased competition, while the OEM business experienced rapid growth [1][2] Revenue Performance - Beverage revenue in 1H25 increased by 7.6% year-on-year, with tea beverage revenue up 9.1%, and specific products like Double Brew and Spring Green Tea achieving double-digit growth [1] - Food revenue grew by 8.8% year-on-year, with notable contributions from products like Qie Huang and Lao Tan Sauerkraut, which saw double-digit growth [1][2] OEM Business Growth - Other business revenue surged by 91.8% year-on-year, with the OEM business more than doubling, driven by major clients such as Sam's Club and other retail private labels [2] - The expansion of private label brands in retail is expected to sustain growth in the OEM business and enhance market insight capabilities [2] Profitability and Cost Management - The gross margin improved in 1H25, with an overall increase of 0.5 percentage points, driven by cost reductions and enhanced capacity utilization [2] - The beverage gross margin rose by 1.4 percentage points, while the food gross margin decreased by 0.4 percentage points due to rising palm oil prices, although the company managed to mitigate this through improved capacity utilization [2] Future Outlook - The company anticipates slight pressure on beverage revenue growth in 3Q due to intensified competition, but expects overall steady growth for the year [3] - Profit margins are expected to remain stable in the second half of the year, supported by declining raw material prices and improved capacity utilization [3] Earnings Forecast and Valuation - The earnings forecast for 2025 and 2026 has been raised by 3% to 2.29 billion yuan and 2.62 billion yuan, respectively [3] - The current trading multiples are 16x and 14x for 2025 and 2026 P/E, with a target price of 11.5 HKD, indicating a 24% upside potential [3]

Investment Rating - The report maintains an "Outperform" rating for the company, indicating a positive outlook on its performance relative to the market [2][9]. Core Insights - The company reported a strong performance in H1 2025, with revenue reaching RMB 17.087 billion, a year-on-year increase of 10.6%, and a net profit of RMB 1.287 billion, up 33.2% year-on-year, exceeding expectations [9]. - The upward revision of profit forecasts is attributed to the decline in raw material prices, improved capacity utilization, and cost optimization, with projected net profits for 2025-2027 being RMB 2.315 billion, RMB 2.579 billion, and RMB 2.843 billion respectively, reflecting year-on-year growth rates of 25%, 11%, and 10% [9]. - The company is recognized as an industry leader, with its food business driving structural upgrades in instant noodles and its beverage segment expanding its multi-category layout [9]. Financial Data and Profit Forecast - Revenue projections for the company are as follows: - 2023: RMB 28.591 billion - 2024: RMB 30.332 billion - 2025E: RMB 32.364 billion - 2026E: RMB 34.473 billion - 2027E: RMB 36.580 billion - The expected growth rates for revenue are 1.2%, 6.1%, 6.7%, 6.5%, and 6.1% respectively [3][10]. - Net profit forecasts are as follows: - 2023: RMB 1.667 billion - 2024: RMB 1.849 billion - 2025E: RMB 2.315 billion - 2026E: RMB 2.579 billion - 2027E: RMB 2.843 billion - The projected year-on-year growth rates for net profit are 36.4%, 11.0%, 25.2%, 11.4%, and 10.2% respectively [3][10]. Business Segment Performance - The food segment achieved a revenue of RMB 5.382 billion in H1 2025, with an 8.8% year-on-year growth, driven primarily by the instant noodle business [9]. - The beverage segment reported a revenue of RMB 10.788 billion, reflecting a 7.6% year-on-year increase, with notable growth in tea, juice, and milk tea categories [9]. Margin and Cost Efficiency - The company achieved a gross margin of 34.32% in H1 2025, an increase of 0.48 percentage points year-on-year, driven by lower raw material costs and improved capacity utilization [9]. - The sales expense ratio decreased to 22.08%, down 1.17 percentage points year-on-year, due to optimized expense management [9].

Core Viewpoint - The domestic new energy passenger vehicle sales have been positive since 2015, with a rapid increase in the electrification penetration rate of commercial vehicles, contributing significant growth [1] Group 1: Market Trends - The sales of new energy vehicles in Europe are expected to maintain a year-on-year growth of over 20% this year [1] - The profitability model for energy storage in China is gradually improving, with various regions implementing the "136 Document" to support policies, indicating a positive outlook for future demand [1] Group 2: Supply Chain Dynamics - The release of new production capacity in the battery and materials sector has significantly slowed down, leading to an expected continuous increase in capacity utilization rates across the lithium battery industry chain [1] - In a non-involution environment, the profitability of the battery and materials sectors is expected to continue improving, achieving simultaneous growth in volume and profit [1]

Group 1 - The core viewpoint of the article highlights the strong financial performance of Yingke Medical, with significant revenue and profit growth in 2024 [1][3] - Yingke Medical reported a revenue of 9.523 billion yuan in 2024, representing a year-on-year increase of 37.65% [1][3] - The net profit for 2024 reached 1.492 billion yuan, showing a substantial year-on-year growth of 284.54% [1][3] Group 2 - The annual production capacity of disposable gloves increased from 79 billion units at the end of March 2024 to 87 billion units by the end of March 2025, with a capacity utilization rate of 96.10% [1][3] - The company holds a significant amount of unconverted USD and has increased short-term borrowings to meet operational funding needs, with short-term borrowings rising to 12.666 billion yuan by the end of 2024 [1] - Yingke Medical maintains a strong liquidity position, with cash and cash equivalents amounting to 12.014 billion yuan and trading financial assets of 6.737 billion yuan at the end of 2024 [1]